Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study

Mats Sjöberg; Andrea Walch; Mina Meshkat; Anders Gustavsson; Gunnar Järnerot; Harald Vogelsang; Erik Hertervig; Gottfried Novacek; Ingalill Friis-Liby; Lars Blomquist; Sieglinde Angelberger; Per Karlen; Christer Grännö; Mogens Vilien; Magnus Ström; Hans Verbaan; Per M Hellström; Clemens Dejaco; Anders Magnuson; Jonas Halfvarson; Walter Reinisch; Curt Tysk

doi:10.1002/ibd.21680

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study

Mats Sjöberg, Andrea Walch, Mina Meshkat, Anders Gustavsson, Gunnar Järnerot, Harald Vogelsang, Erik Hertervig, Gottfried Novacek, Ingalill Friis-Liby, Lars Blomquist, Sieglinde Angelberger, Per Karlen, Christer Grännö, Mogens Vilien, Magnus Ström, Hans Verbaan, Per M Hellström, Clemens Dejaco, Anders Magnuson, Jonas HalfvarsonWalter Reinisch, Curt Tysk

Department of Surgery

60 Citations (Scopus)

Abstract

Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.

Original language	English
Journal	Inflammatory Bowel Diseases
Volume	18
Issue number	2
Pages (from-to)	212-8
Number of pages	7
ISSN	1078-0998
DOIs	https://doi.org/10.1002/ibd.21680
Publication status	Published - 2012

Access to Document

10.1002/ibd.21680

Cite this

Sjöberg, M., Walch, A., Meshkat, M., Gustavsson, A., Järnerot, G., Vogelsang, H., Hertervig, E., Novacek, G., Friis-Liby, I., Blomquist, L., Angelberger, S., Karlen, P., Grännö, C., Vilien, M., Ström, M., Verbaan, H., Hellström, P. M., Dejaco, C., Magnuson, A., ... Tysk, C. (2012). Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflammatory Bowel Diseases, 18(2), 212-8. https://doi.org/10.1002/ibd.21680

Sjöberg, M, Walch, A, Meshkat, M, Gustavsson, A, Järnerot, G, Vogelsang, H, Hertervig, E, Novacek, G, Friis-Liby, I, Blomquist, L, Angelberger, S, Karlen, P, Grännö, C, Vilien, M, Ström, M, Verbaan, H, Hellström, PM, Dejaco, C, Magnuson, A, Halfvarson, J, Reinisch, W & Tysk, C 2012, 'Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study', Inflammatory Bowel Diseases, vol. 18, no. 2, pp. 212-8. https://doi.org/10.1002/ibd.21680

@article{f33a6b8a0621459f8a02cf0a1fd716c1,

title = "Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study",

abstract = "Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.",

author = "Mats Sj{\"o}berg and Andrea Walch and Mina Meshkat and Anders Gustavsson and Gunnar J{\"a}rnerot and Harald Vogelsang and Erik Hertervig and Gottfried Novacek and Ingalill Friis-Liby and Lars Blomquist and Sieglinde Angelberger and Per Karlen and Christer Gr{\"a}nn{\"o} and Mogens Vilien and Magnus Str{\"o}m and Hans Verbaan and Hellstr{\"o}m, \{Per M\} and Clemens Dejaco and Anders Magnuson and Jonas Halfvarson and Walter Reinisch and Curt Tysk",

note = "Copyright {\textcopyright} 2011 Crohn's \& Colitis Foundation of America, Inc.",

year = "2012",

doi = "10.1002/ibd.21680",

language = "English",

volume = "18",

pages = "212--8",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis

T2 - a retrospective observational study

AU - Sjöberg, Mats

AU - Walch, Andrea

AU - Meshkat, Mina

AU - Gustavsson, Anders

AU - Järnerot, Gunnar

AU - Vogelsang, Harald

AU - Hertervig, Erik

AU - Novacek, Gottfried

AU - Friis-Liby, Ingalill

AU - Blomquist, Lars

AU - Angelberger, Sieglinde

AU - Karlen, Per

AU - Grännö, Christer

AU - Vilien, Mogens

AU - Ström, Magnus

AU - Verbaan, Hans

AU - Hellström, Per M

AU - Dejaco, Clemens

AU - Magnuson, Anders

AU - Halfvarson, Jonas

AU - Reinisch, Walter

AU - Tysk, Curt

PY - 2012

Y1 - 2012

N2 - Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.

AB - Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.

UR - https://www.scopus.com/pages/publications/84855698480

U2 - 10.1002/ibd.21680

DO - 10.1002/ibd.21680

M3 - Journal article

C2 - 21438096

SN - 1078-0998

VL - 18

SP - 212

EP - 218

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 2

ER -

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this